Physician profile
John E Montgomery
NPI 1033142898
$1,048.35
in general payments reported to CMS, 2019-2025
18 companies · $224 in 2025
The $224 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $138 · 2022: $36.13 · 2024: $341 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $213.94 | 2019-2024 | |
| Tris Pharma INC | $209.39 | 2019-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $121.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $71.97 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Collegium Pharmaceutical, INC. | $66.71 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $66.00 | 2024-2025 | Qelbree |
| Neos Therapeutics, Lp | $49.75 | 2019 | |
| Pfizer INC. | $47.24 | 2024-2025 | |
| Vertical Pharmaceuticals, LLC | $30.39 | 2025 | Relexxii |
| Cranial Technologies, INC | $30.33 | 2019-2024 | Doc Band |
| Astrazeneca Pharmaceuticals Lp | $29.74 | 2024 | Flumist Quadrivalent |
| Sobi, INC | $19.04 | 2019 | |
| Corium, LLC | $18.80 | 2025 | Azstarys |
| Medline Industries Lp | $16.85 | 2020 | |
| Kaleo, INC. | $16.54 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immedica Pharma US, INC. | $16.12 | 2024 | |
| Adlon Therapeutics L.P. | $13.30 | 2020 | |
| Genentech USA, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.